Gene · 2813
NIH grants1,628
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 1,628
Download this page as JSON| Grant | Title | GP2 papers | Newest fiscal year |
|---|---|---|---|
| U01DK085535 | Intestinal Stem Cell Culture and Entero-Endocrine Lineage Development | 1 | 2018 |
| U01EB012493 | Point-of care Microfluidics for Early Detection of Cancer | 1 | 2018 |
| U10CA180827 | ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER | 1 | 2018 |
| U19AI109776 | Immunoprophylactic Strategies to Control Emerging Enteric Infections | 1 | 2018 |
| U19AI109965 | Discovery of New Innate Immune Pathways in Viral Recognition | 1 | 2018 |
| UM1AI100645 | Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery | 1 | 2018 |
| UM1CA182913 | The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up | 1 | 2018 |
| ZIAAI005002 | HIV/AIDS Vaccine Development | 1 | 2018 |
| ZIACL090018 | Computer-Aided Detection for Infectious Disease Imaging | 1 | 2018 |
| ZIDAI009006 | Integrated Research Facility at Fort Detrick | 1 | 2018 |
| R01AI104621 | Antibody immunotherapeutics for biodefense against Lassa virus | 8 | 2017 |
| R21AI121840 | A General Molecular Strategy for Attenuation of Human Pathogenic Arenaviruses | 8 | 2017 |
| R21AI121550 | Broadly Neutralizing Antibodies Against Human Pathogenic Old World Arenaviruses | 5 | 2017 |
| R01AI114776 | Combinations of Approved Drugs to Combat Ebola Virus | 4 | 2017 |
| R41AI126971 | 4-(Aminomethyl) benzamides as novel anti-Ebola agents | 4 | 2017 |
| P41GM103311 | Resource for Biocomputing Visualization and Informatics | 3 | 2017 |
| P41GM103403 | NE-CAT Center for Advanced Macromolecular Crystallography | 3 | 2017 |
| R01AI102887 | Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses | 3 | 2017 |
| R21EB021511 | Enhanced molecular imaging agents via designed ligand charge | 3 | 2017 |
| R01AI105204 | Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine | 2 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/grants?page=40